In the plasma of COVID-19 patients, the infection-related elevation of IL-6 and IL-6R results in a boost of endothelial cells and TF [14] and this infection-induced coagulopathy may play a pivotal role in thrombocytopenia, while the cytokine storm triggers the thrombocytosis [14]. This evidence concerns the gene IL6R and blood coagulation disease.